|
101
|
271
|
2f4bA |
Crystal structure of the ligand binding domain of human ppar-gamma in complex with an agonist |
|
88
|
244
|
2faiA |
Human estrogen receptor alpha ligand-binding domain in complex with obcp-2m and a glucocorticoid receptor interacting protein 1 nr box ii peptide |
|
91
|
227
|
2e2rA |
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol a |
|
98
|
265
|
2bawA |
Human nuclear receptor-ligand complex 1 |
|
86
|
226
|
2bj4B |
Estrogen receptor alpha lbd in complex with a phage-display derived peptide antagonist |
|
80
|
244
|
2b23A |
Human estrogen receptor alpha ligand-binding domain and a glucocorticoid receptor-interacting protein 1 nr box ii peptide |
|
94
|
246
|
2ax9A |
Crystal structure of the androgen receptor ligand binding domain in complex with r-3 |
|
90
|
246
|
2ayrA |
A serm designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats |
|
99
|
246
|
2ax7A |
Crystal structure of the androgen receptor ligand binding domain t877a mutant in complex with s-1 |
|
93
|
246
|
2ax8A |
Crystal structure of the androgen receptor ligand binding domain w741l mutant in complex with s-1 |
|
88
|
224
|
2bj4A |
Estrogen receptor alpha lbd in complex with a phage-display derived peptide antagonist |
|
104
|
268
|
2awhA |
Human nuclear receptor-ligand complex 1 |
|
97
|
271
|
2athA |
Crystal structure of the ligand binding domain of human ppar-gamma im complex with an agonist |
|
87
|
244
|
2b1zA |
Human estrogen receptor alpha ligand-binding domain in complex with 17methyl-17alpha-dihydroequilenin and a glucoc interacting protein 1 nr box ii peptide |
|
102
|
266
|
2b50A |
Human nuclear receptor-ligand complex 2 |
|
98
|
247
|
2ax6A |
Crystal structure of the androgen receptor ligand binding domain t877a mutant in complex with hydroxyflutamide |
|
95
|
246
|
2axaA |
Crystal structure of the androgen receptor ligand binding domain in complex with s-1 |
|
88
|
244
|
2b1vA |
Human estrogen receptor alpha ligand-binding domain in complex with obcp-1m and a glucocorticoid receptor interacting protein 1 nr box ii peptide |
|
99
|
249
|
2amaA |
Crystal structure of human androgen receptor ligand binding domain in complex with dihydrotestosterone |
|
85
|
242
|
2aclB |
Liver x-receptor alpha ligand binding domain with sb313987 |
|
73
|
233
|
2aclA |
Liver x-receptor alpha ligand binding domain with sb313987 |
|
103
|
249
|
2ambA |
Crystal structure of human androgen receptor ligand binding domain in complex with tetrahydrogestrinone |
|
95
|
248
|
2ao6A |
Crystal structure of the human androgen receptor ligand binding domain bound with tif2(iii) 740-753 peptide and r1881 |
|
93
|
261
|
2aa5A |
Mineralocorticoid receptor with bound progesterone |
|
103
|
250
|
2am9A |
Crystal structure of human androgen receptor ligand binding domain in complex with testosterone |
|
100
|
261
|
2aa6A |
Mineralocorticoid receptor s810l mutant with bound progesterone |
|
96
|
251
|
1zucA |
Progesterone receptor ligand binding domain in complex with the nonsteroidal agonist tanaproget |
|
91
|
271
|
1zeoA |
Crystal structure of human ppar-gamma ligand binding domain complexed with an alpha-aryloxyphenylacetic acid agonist |
|
92
|
257
|
2aa7A |
Mineralocorticoid receptor with bound deoxycorticosterone |
|
99
|
272
|
1zgyA |
Structural and biochemical basis for selective repression of the orphan nuclear receptor lrh-1 by shp |
|
89
|
238
|
1zafA |
Crystal structure of estrogen receptor beta complexed with 3-bromo-6-hydroxy-2-(4-hydroxy-phenyl)-inden-1-one |
|
89
|
246
|
1zkyA |
Human estrogen receptor alpha ligand-binding domain in complex with obcp-3m and a glucocorticoid receptor interacting protein 1 nr box ii peptide |
|
87
|
246
|
2abiA |
Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to deoxycorticosterone |
|
91
|
240
|
1zduA |
The crystal structure of human liver receptor homologue-1 |
|
92
|
243
|
1zh7A |
Structural and biochemical basis for selective repression of the orphan nuclear receptor lrh-1 by shp |
|
93
|
246
|
1z95A |
Crystal structure of the androgen receptor ligand-binding domain w741l mutant complex with r-bicalutamide |
|
93
|
257
|
2aa2A |
Mineralocorticoid receptor with bound aldosterone |
|
98
|
262
|
2aaxA |
Mineralocorticoid receptor double mutant with bound cortisone |
|
98
|
260
|
2ab2A |
Mineralocorticoid receptor double mutant with bound spironolactone |
|
85
|
240
|
1zdtA |
The crystal structure of human steroidogenic factor-1 |
|
102
|
253
|
2a3iA |
Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor |
|
88
|
235
|
1yy4A |
Crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol |
|
69
|
193
|
1z5xU |
Hemipteran ecdysone receptor ligand-binding domain complexed with ponasterone a |
|
92
|
238
|
1yyeA |
Crystal structure of estrogen receptor beta complexed with way-202196 |
|
90
|
237
|
1z5xE |
Hemipteran ecdysone receptor ligand-binding domain complexed with ponasterone a |
|
96
|
239
|
1yp0A |
Structure of the steroidogenic factor-1 ligand binding domain bound to phospholipid and a shp peptide motif |
|
93
|
262
|
1y0xX |
Thyroxine-thyroid hormone receptor interactions |
|
101
|
243
|
1ymtA |
Mouse sf-1 lbd |
|
85
|
247
|
1y9rA |
Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to deoxycorticosterone and harboring the s810l mutation responsible for a severe form of hypertension |
|
88
|
238
|
1yowA |
Human steroidogenic factor 1 lbd with bound co-factor peptide |
